NeuACT, a phase II, randomized, open-label trial of DN24-02: Updated analysis of HER2 expression, immune responses, product parameters, and safety in patients with surgically resected HER2+urothelial cancer Meeting Abstract
| Authors: | Bajorin, D. F.; Sharma, P.; Gomella, L. G.; Plimack, E. R.; O'Donnell, P. H.; Hoffman-Censits, J. H.; Flaig, T. W.; Quinn, D. I.; Sims, R. B.; Locker, M.; Sheikh, N. A.; DeVries, T.; Lerner, S. P. |
| Abstract Title: | NeuACT, a phase II, randomized, open-label trial of DN24-02: Updated analysis of HER2 expression, immune responses, product parameters, and safety in patients with surgically resected HER2+urothelial cancer |
| Meeting Title: | 2014 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2014 Jan 30-Feb 1 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-02-01 |
| Language: | English |
| ACCESSION: | WOS:000335318100297 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.4_suppl.296 |
| Notes: | Meeting Abstract: 296 -- Genitourinary Cancers Symposium -- JAN 30-FEB 01, 2014 -- San Francisco, CA -- S -- Source: Wos |
